Citigroup’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-906,013
| Closed | -$3.81M | – | 5901 |
|
|
2023
Q1 | $3.81M | Buy |
906,013
+263,892
| +41% | +$1.37M | ﹤0.01% | 1640 |
|
|
2022
Q4 | $3.86M | Sell |
642,121
-347,325
| -35% | -$1.9M | ﹤0.01% | 1610 |
|
|
2022
Q3 | $5.76M | Buy |
989,446
+547,603
| +124% | +$3.41M | ﹤0.01% | 1471 |
|
|
2022
Q2 | $2.64M | Buy |
441,843
+359,425
| +436% | +$1.84M | ﹤0.01% | 1917 |
|
|
2022
Q1 | $385K | Buy |
+82,418
| New | +$246K | ﹤0.01% | 3680 |
|
|
2021
Q3 | – | Sell |
-3
| Closed | – | – | 6583 |
|
|
2021
Q2 | $0 | Sell |
3
-26,560
| -100% | -$63.7K | ﹤0.01% | 6634 |
|
|
2021
Q1 | $77K | Buy |
26,563
+2,419
| +10% | +$7.9K | ﹤0.01% | 4495 |
|
|
2020
Q4 | $78K | Buy |
24,144
+24,141
| +804,700% | +$80.3K | ﹤0.01% | 5737 |
|
|
2020
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 7786 |
|
|
2020
Q2 | $0 | Sell |
3
-20
| -87% | -$21 | ﹤0.01% | 7881 |
|
|
2020
Q1 | $0 | Hold |
23
| – | – | ﹤0.01% | 7985 |
|
|
2019
Q4 | $0 | Sell |
23
-5,761
| -100% | -$5.46K | ﹤0.01% | 7984 |
|
|
2019
Q3 | $5K | Sell |
5,784
-1,950
| -25% | -$1.49K | ﹤0.01% | 7377 |
|
|
2019
Q2 | $7K | Sell |
7,734
-6,136
| -44% | -$5.66K | ﹤0.01% | 7419 |
|
|
2019
Q1 | $14K | Buy |
13,870
+292
| +2% | +$307 | ﹤0.01% | 7135 |
|
|
2018
Q4 | $10K | Sell |
13,578
-1,848
| -12% | -$3.04K | ﹤0.01% | 7178 |
|
|
2018
Q3 | $33K | Buy |
15,426
+7,961
| +107% | +$19.7K | ﹤0.01% | 6845 |
|
|
2018
Q2 | $38K | Buy |
7,465
+7,339
| +5,825% | +$32.1K | ﹤0.01% | 6501 |
|
|
2018
Q1 | $0 | Buy |
126
+20
| +19% | +$70 | ﹤0.01% | 7862 |
|
|
2017
Q4 | $0 | Sell |
106
-20
| -16% | -$59 | ﹤0.01% | 7820 |
|
|
2017
Q3 | $0 | Hold |
126
| – | – | ﹤0.01% | 7700 |
|
|
2017
Q2 | $0 | Hold |
126
| – | – | ﹤0.01% | 7719 |
|
|
2017
Q1 | $0 | Sell |
126
-1
| -0.8% | -$5 | ﹤0.01% | 7547 |
|
|
2016
Q4 | $0 | Hold |
127
| – | – | ﹤0.01% | 7518 |
|
|
2016
Q3 | $0 | Sell |
127
-10
| -7% | -$36 | ﹤0.01% | 7414 |
|
|
2016
Q2 | $0 | Sell |
137
-19,045
| -99% | -$87.4K | ﹤0.01% | 7893 |
|
|
2016
Q1 | $102K | Buy |
19,182
+12,618
| +192% | +$101K | ﹤0.01% | 5652 |
|
|
2015
Q4 | $80K | Buy |
6,564
+6,401
| +3,927% | +$85.5K | ﹤0.01% | 5560 |
|
|
2015
Q3 | $2K | Sell |
163
-461
| -74% | -$7.97K | ﹤0.01% | 7106 |
|
|
2015
Q2 | $12K | Sell |
624
-847
| -58% | -$16.3K | ﹤0.01% | 6391 |
|
|
2015
Q1 | $27K | Sell |
1,471
-1,357
| -48% | -$30.5K | ﹤0.01% | 5926 |
|
|
2014
Q4 | $67K | Buy |
2,828
+2,222
| +367% | +$51.4K | ﹤0.01% | 5506 |
|
|
2014
Q3 | $15K | Sell |
606
-1,209
| -67% | -$31.4K | ﹤0.01% | 6081 |
|
|
2014
Q2 | $52K | Sell |
1,815
-1,074
| -37% | -$32.3K | ﹤0.01% | 5151 |
|
|
2014
Q1 | $98K | Sell |
2,889
-9,212
| -76% | -$315K | ﹤0.01% | 5013 |
|
|
2013
Q4 | $233K | Buy |
12,101
+6,322
| +109% | +$115K | ﹤0.01% | 4521 |
|
|
2013
Q3 | $95K | Buy |
5,779
+579
| +11% | +$6.71K | ﹤0.01% | 4774 |
|
|
2013
Q2 | $55K | Buy |
+5,200
| New | +$60.9K | ﹤0.01% | 5326 |
|
Other funds holding CTIC
Citigroup's CTIC Position: Q2 2023 in Review
Citigroup sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 906,013 shares — an estimated $3.81M sold.
Citigroup first reported a position in CTIC in Q2 2013 and held it in 38 quarters. The position peaked at $5.76M in Q3 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.
- Citigroup reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
- Citigroup sold 906,013 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $3.81M.
- Citigroup first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 38 quarters.
- Citigroup's CTI BioPharma Corp. (DE) Common Stock position peaked at $5.76M in Q3 2022.
- 2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.
Based on Citigroup's 13F filing for Q2 2023, filed 10 Aug 2023.